Health partners in Mozambique and The Global Fund collectively launched six grants on February 8, 2018 to accelerate the end of epidemics of HIV, tuberculosis (TB) and malaria
Health partners in Mozambique and The Global Fund collectively launched six grants on February 8, 2018 to accelerate the end of epidemics of HIV, tuberculosis (TB) and malaria.
Worth US$515 million, the grants aim to support the reduction of rates of death and sickness caused by malaria by 40% by 2022 from 2015 figures.
They will also go towards reducing new HIV infections and finding missing cases of TB, as well as reducing HIV-related deaths by 40%, and TB-related death rates by 50%, by 2020.
The grants will cover an implementation period of 2018-20 and will be controlled by the Ministry of Health and civil society organisations.
Since 2013, Mozambique’s partnerships with global health partners has enabled a rapid expansion of HIV treatment, with the number of patients on antiretroviral therapy increased from 300,000 in 2012 to over 1 million in 2017, and more than 16 million mosquito nets distributed between 2016 and 2017.
Furthermore, more than 73,000 people have been treated for TB by the Global Fund partnership.
Minister for Health in Mozambique Nazira Abdula said: “Support from the Global Fund, which goes back to 2002, has been fundamental in fighting HIV, tuberculosis and malaria in Mozambique.
“We have made significant progress against these diseases and reiterate our commitment to manage these funds efficiently for better health of our population.”
Linden Morrison, Head of the Global Fund’s High Impact Africa II Department, said: “Mozambique has made remarkable progress against HIV, tuberculosis and malaria in the last decade.
“That impact is a result of the great efforts by the people of Mozambique in partnership with global health partners.
“Together, we can end these diseases as epidemics in Mozambique by 2030.”
